Definitive Healthcare Corp. (DH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 90M 180M 270M Q4 '20: 118.3M Q1 '21: 128.9M Q2 '21: 140.5M Q3 '21: 153.5M Q4 '21: 166.2M Q1 '22: 179.3M Q2 '22: 194.1M Q3 '22: 208.4M Q4 '22: 222.7M Q1 '23: 231.7M Q2 '23: 238.1M Q3 '23: 246.1M Q4 '23: 251.4M Q1 '24: 255.7M Q2 '24: 258.5M Q3 '24: 255.8M Q4 '24: 252.2M Q1 '25: 247.9M Q2 '25: 244.9M Q3 '25: 242.3M Q4 '25: 241.5M Q1 '26: 238.3M Q2 '26: 232.7M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 80M 160M 240M Q4 '20: 87.8M Q1 '21: 96.4M Q2 '21: 105.5M Q3 '21: 115.4M Q4 '21: 125.5M Q1 '22: 136.8M Q2 '22: 149.6M Q3 '22: 164.6M Q4 '22: 180M Q1 '23: 188.5M Q2 '23: 195.5M Q3 '23: 201.3M Q4 '23: 203.9M Q1 '24: 207M Q2 '24: 207.7M Q3 '24: 203.3M Q4 '24: 197.5M Q1 '25: 190.8M Q2 '25: 187M Q3 '25: 184M Q4 '25: 183.3M Q1 '26: 181.2M Q2 '26: 175.1M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-900M -600M -300M 0 300M 600M 900M Q4 '20: -15.6M Q1 '21: -13M Q2 '21: -17.2M Q3 '21: -20.3M Q4 '21: -25.9M Q1 '22: -35.3M Q2 '22: -40.6M Q3 '22: -46.6M Q4 '22: -44M Q1 '23: -44.7M Q2 '23: -44.9M Q3 '23: -330.3M Q4 '23: -329.8M Q1 '24: -333.8M Q2 '24: -691.3M Q3 '24: -621.3M Q4 '24: -710.8M Q1 '25: -879.4M Q2 '25: -513.9M Q3 '25: -297.2M Q4 '25: -224.3M Q1 '26: -240.8M Q2 '26: -243.4M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-600M -400M -200M 0 200M 400M 600M Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: -8M Q4 '21: -17.8M Q1 '22: -26.4M Q2 '22: -31.9M Q3 '22: -26.9M Q4 '22: -7.2M Q1 '23: -10.7M Q2 '23: -13.8M Q3 '23: -182.3M Q4 '23: -202.4M Q1 '24: -199.8M Q2 '24: -404.9M Q3 '24: -364.3M Q4 '24: -413.1M Q1 '25: -510.8M Q2 '25: -304.8M Q3 '25: -188.7M Q4 '25: -138.9M Q1 '26: -170.3M Q2 '26: -168.2M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 20M 40M 60M Q4 '20: 11.1M Q1 '21: 12.6M Q2 '21: 14.6M Q3 '21: 17.1M Q4 '21: 19.4M Q1 '22: 21.2M Q2 '22: 22.8M Q3 '22: 24.2M Q4 '22: 25.9M Q1 '23: 28.5M Q2 '23: 30.3M Q3 '23: 32.4M Q4 '23: 34.7M Q1 '24: 39.3M Q2 '24: 44.5M Q3 '24: 49.5M Q4 '24: 54.7M Q1 '25: 57.1M Q2 '25: 57.9M Q3 '25: 58.3M Q4 '25: 58.2M Q1 '26: 57.1M Q2 '26: 57.6M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 25M 50M 75M Q3 '21: 29.7M Q4 '21: 25.2M Q1 '22: 25.3M Q2 '22: 32.4M Q3 '22: 44M Q4 '23: 41.2M Q1 '24: 42.8M Q2 '24: 44.8M Q3 '24: 54.8M Q4 '24: 58.2M Q1 '25: 67.7M Q2 '25: 62.9M Q3 '25: 59.2M Q4 '25: 53.8M Q1 '26: 39.3M Q2 '26: 41.4M Q4 '21 Q2 '22 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow TTM

0 20M 40M 60M Q4 '21: 18.5M Q1 '22: 21.6M Q2 '22: 29.3M Q3 '22: 39.5M Q4 '23: 38.2M Q1 '24: 40.9M Q2 '24: 43.2M Q3 '24: 52.7M Q4 '24: 45.9M Q1 '25: 47.9M Q2 '25: 41.3M Q3 '25: 36M Q4 '25: 37.1M Q1 '26: 27.1M Q2 '26: 28.6M Q4 '21 Q2 '22 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q3 '21: 88.3M Q4 '21: 92.6M Q1 '22: 97.2M Q2 '22: 99.2M Q3 '22: 102.9M Q4 '22: 154M Q1 '23: 108.2M Q2 '23: 111.8M Q3 '23: 114.5M Q1 '24: 117.4M Q2 '24: 117.8M Q3 '24: 116.4M Q1 '25: 112.8M Q2 '25: 106.8M Q3 '25: 103.8M Q1 '26: 104.7M Q2 '26: 105.8M Q4 '21 Q3 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '22: -0.35 Q3 '22: -0.29 Q4 '22: -0.12 Q1 '23: -0.14 Q2 '23: -0.16 Q3 '23: -1.63 Q4 '23: -1.76 Q1 '24: -1.73 Q2 '24: -3.46 Q3 '24: -3.08 Q4 '24: -3.53 Q1 '25: -4.40 Q2 '25: -2.66 Q3 '25: -1.68 Q4 '25: -1.26 Q1 '26: -1.63 Q2 '26: -1.61 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.